Detalles de la búsqueda
1.
Effectiveness and safety of empagliflozin: final results from the EMPRISE study.
Diabetologia
; 2024 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38509341
2.
A population-based cohort defined risk of hyperkalemia after initiating SGLT-2 inhibitors, GLP1 receptor agonists or DPP-4 inhibitors to patients with chronic kidney disease and type 2 diabetes.
Kidney Int
; 105(3): 618-628, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38101515
3.
Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study.
Cardiovasc Diabetol
; 23(1): 57, 2024 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38331813
4.
Empagliflozin and Risk of Incident Gout: Analysis from the EMPagliflozin Comparative Effectiveness and SafEty (EMPRISE) Cohort Study.
J Gen Intern Med
; 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38710868
5.
Stratified analysis in comparative effectiveness studies that emulate randomized trials.
Pharmacoepidemiol Drug Saf
; 33(1): e5716, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37876341
6.
Successful implementation of a stakeholder engagement program for pharmacoepidemiologic research.
Pharmacoepidemiol Drug Saf
; 33(1): e5727, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37985010
7.
Sodium-glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort study.
Eur Heart J
; 44(24): 2216-2230, 2023 06 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37259575
8.
Safety of SGLT2i with regard to bone and mineral metabolism in patients with CKD.
Curr Opin Nephrol Hypertens
; 32(4): 324-329, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37195239
9.
Contemporary trends in the utilization of second-line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom.
Diabetes Obes Metab
; 25(10): 2980-2988, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37395339
10.
Achieving comparability in glycemic control between antidiabetic treatment strategies in pregnancy when using real world data.
Pharmacoepidemiol Drug Saf
; 32(12): 1350-1359, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37461243
11.
Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin : A Cohort Study.
Ann Intern Med
; 175(7): 927-937, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35605236
12.
Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses: Results of 32 Clinical Trials.
JAMA
; 329(16): 1376-1385, 2023 04 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37097356
13.
Risk of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-1RA Therapy.
Circulation
; 143(8): 770-779, 2021 02 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33302723
14.
Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative.
Circulation
; 143(10): 1002-1013, 2021 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33327727
15.
Glucagon-Like Peptide 1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: A Multisite Population-Based Cohort Study.
Am J Epidemiol
; 191(8): 1352-1367, 2022 07 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35136902
16.
Glucagon-Like Peptide-1 Receptor Agonists and Hepatic Decompensation Events in Patients With Cirrhosis and Diabetes.
Clin Gastroenterol Hepatol
; 20(6): 1382-1393.e19, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34256144
17.
Comparative effectiveness of Empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical care.
Am Heart J
; 254: 203-215, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36150454
18.
SGLT2 Inhibitors and the Risk of Acute Kidney Injury in Older Adults With Type 2 Diabetes.
Am J Kidney Dis
; 79(6): 858-867.e1, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34762974
19.
Risk of Hospitalization for Heart Failure in Patients With Hyperkalemia Treated With Sodium Zirconium Cyclosilicate Versus Patiromer.
J Card Fail
; 28(9): 1414-1423, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35470055
20.
Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis.
Cardiovasc Diabetol
; 21(1): 47, 2022 03 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35321742